UA19871U - Diagnostic device for detecting analyte - Google Patents

Diagnostic device for detecting analyte Download PDF

Info

Publication number: UA19871U
Authority: UA; Ukraine
Prior art keywords: conjugate; test strip; test; sample; strip according
Prior art date: 2003-06-06

Application number

UAU200512159U

Other languages

English (en)

Ukrainian (uk)

Original Assignee

Advantage Diagnostics Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-06-06

Filing date

2004-03-19

Publication date

2007-01-15

2004-03-19 Application filed by Advantage Diagnostics Corp filed Critical Advantage Diagnostics Corp

2007-01-15 Publication of UA19871U publication Critical patent/UA19871U/uk

Links

239000012491 analyte Substances 0.000 title claims abstract description 79
238000012360 testing method Methods 0.000 claims abstract description 421
230000027455 binding Effects 0.000 claims abstract description 34
239000012528 membrane Substances 0.000 claims description 134
239000000872 buffer Substances 0.000 claims description 128
239000011534 wash buffer Substances 0.000 claims description 63
239000000427 antigen Substances 0.000 claims description 56
102000036639 antigens Human genes 0.000 claims description 56
108091007433 antigens Proteins 0.000 claims description 56
239000002250 absorbent Substances 0.000 claims description 40
230000002745 absorbent Effects 0.000 claims description 40
239000011230 binding agent Substances 0.000 claims description 33
239000007788 liquid Substances 0.000 claims description 29
235000018102 proteins Nutrition 0.000 claims description 20
102000004169 proteins and genes Human genes 0.000 claims description 20
108090000623 proteins and genes Proteins 0.000 claims description 20
241000725303 Human immunodeficiency virus Species 0.000 claims description 18
210000002700 urine Anatomy 0.000 claims description 15
PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims description 14
239000002981 blocking agent Substances 0.000 claims description 13
239000005018 casein Substances 0.000 claims description 11
BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 claims description 11
235000021240 caseins Nutrition 0.000 claims description 11
239000000020 Nitrocellulose Substances 0.000 claims description 10
210000004369 blood Anatomy 0.000 claims description 10
239000008280 blood Substances 0.000 claims description 10
239000012530 fluid Substances 0.000 claims description 10
229920001220 nitrocellulos Polymers 0.000 claims description 10
238000011144 upstream manufacturing Methods 0.000 claims description 10
238000004891 communication Methods 0.000 claims description 9
210000002381 plasma Anatomy 0.000 claims description 9
210000002966 serum Anatomy 0.000 claims description 9
102000011022 Chorionic Gonadotropin Human genes 0.000 claims description 8
108010062540 Chorionic Gonadotropin Proteins 0.000 claims description 8
229940084986 human chorionic gonadotropin Drugs 0.000 claims description 8
239000002245 particle Substances 0.000 claims description 6
208000031886 HIV Infections Diseases 0.000 claims description 5
241000711549 Hepacivirus C Species 0.000 claims description 5
241000713772 Human immunodeficiency virus 1 Species 0.000 claims description 5
241000283973 Oryctolagus cuniculus Species 0.000 claims description 5
241000713340 Human immunodeficiency virus 2 Species 0.000 claims description 4
239000002736 nonionic surfactant Substances 0.000 claims description 3
GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 claims description 3
BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 claims description 2
239000006229 carbon black Substances 0.000 claims description 2
238000002405 diagnostic procedure Methods 0.000 claims description 2
239000004816 latex Substances 0.000 claims description 2
229920000126 latex Polymers 0.000 claims description 2
108010058683 Immobilized Proteins Proteins 0.000 claims 1
238000000034 method Methods 0.000 abstract description 11
230000000007 visual effect Effects 0.000 abstract description 11
230000009870 specific binding Effects 0.000 abstract description 6
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 4
208000006454 hepatitis Diseases 0.000 abstract description 3
231100000283 hepatitis Toxicity 0.000 abstract description 3
238000003745 diagnosis Methods 0.000 abstract description 2
201000010099 disease Diseases 0.000 abstract description 2
208000035475 disorder Diseases 0.000 abstract description 2
239000000523 sample Substances 0.000 description 229
239000004033 plastic Substances 0.000 description 26
229920003023 plastic Polymers 0.000 description 26
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 20
239000012723 sample buffer Substances 0.000 description 19
PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 18
239000000463 material Substances 0.000 description 16
239000002274 desiccant Substances 0.000 description 15
150000001875 compounds Chemical class 0.000 description 14
239000003708 ampul Substances 0.000 description 11
102000011632 Caseins Human genes 0.000 description 10
108010076119 Caseins Proteins 0.000 description 10
239000011780 sodium chloride Substances 0.000 description 10
FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 9
229930195725 Mannitol Natural products 0.000 description 9
239000000594 mannitol Substances 0.000 description 9
235000010355 mannitol Nutrition 0.000 description 9
108091003079 Bovine Serum Albumin Proteins 0.000 description 8
229940098773 bovine serum albumin Drugs 0.000 description 8
230000007246 mechanism Effects 0.000 description 8
KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 7
229920004890 Triton X-100 Polymers 0.000 description 7
238000006243 chemical reaction Methods 0.000 description 7
239000011152 fibreglass Substances 0.000 description 7
239000000203 mixture Substances 0.000 description 7
-1 antibodies Proteins 0.000 description 6
230000035945 sensitivity Effects 0.000 description 6
239000004094 surface-active agent Substances 0.000 description 6
208000000143 urethritis Diseases 0.000 description 6
239000006172 buffering agent Substances 0.000 description 5
238000009597 pregnancy test Methods 0.000 description 5
239000003755 preservative agent Substances 0.000 description 5
230000002335 preservative effect Effects 0.000 description 5
239000007787 solid Substances 0.000 description 5
229910019142 PO4 Inorganic materials 0.000 description 4
238000013461 design Methods 0.000 description 4
239000010452 phosphate Substances 0.000 description 4
NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 4
210000003296 saliva Anatomy 0.000 description 4
239000000758 substrate Substances 0.000 description 4
CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
229930006000 Sucrose Natural products 0.000 description 3
239000007983 Tris buffer Substances 0.000 description 3
210000001124 body fluid Anatomy 0.000 description 3
239000010839 body fluid Substances 0.000 description 3
229920002678 cellulose Polymers 0.000 description 3
239000001913 cellulose Substances 0.000 description 3
239000003795 chemical substances by application Substances 0.000 description 3
238000001514 detection method Methods 0.000 description 3
239000011888 foil Substances 0.000 description 3
239000003365 glass fiber Substances 0.000 description 3
230000003993 interaction Effects 0.000 description 3
CXKWCBBOMKCUKX-UHFFFAOYSA-M methylene blue Chemical compound [Cl-].C1=CC(N(C)C)=CC2=[S+]C3=CC(N(C)C)=CC=C3N=C21 CXKWCBBOMKCUKX-UHFFFAOYSA-M 0.000 description 3
229960000907 methylthioninium chloride Drugs 0.000 description 3
238000002156 mixing Methods 0.000 description 3
239000008363 phosphate buffer Substances 0.000 description 3
229920000728 polyester Polymers 0.000 description 3
230000035935 pregnancy Effects 0.000 description 3
239000000243 solution Substances 0.000 description 3
238000005507 spraying Methods 0.000 description 3
239000005720 sucrose Substances 0.000 description 3
235000000346 sugar Nutrition 0.000 description 3
LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 3
HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 2
102000012673 Follicle Stimulating Hormone Human genes 0.000 description 2
108010079345 Follicle Stimulating Hormone Proteins 0.000 description 2
108060003951 Immunoglobulin Proteins 0.000 description 2
HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 2
239000000853 adhesive Substances 0.000 description 2
230000001070 adhesive effect Effects 0.000 description 2
HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 2
230000036436 anti-hiv Effects 0.000 description 2
239000008366 buffered solution Substances 0.000 description 2
239000000356 contaminant Substances 0.000 description 2
238000007865 diluting Methods 0.000 description 2
238000001035 drying Methods 0.000 description 2
239000000284 extract Substances 0.000 description 2
229940028334 follicle stimulating hormone Drugs 0.000 description 2
102000018358 immunoglobulin Human genes 0.000 description 2
NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
230000009871 nonspecific binding Effects 0.000 description 2
108020004707 nucleic acids Proteins 0.000 description 2
102000039446 nucleic acids Human genes 0.000 description 2
150000007523 nucleic acids Chemical class 0.000 description 2
238000002360 preparation method Methods 0.000 description 2
102000004196 processed proteins & peptides Human genes 0.000 description 2
108090000765 processed proteins & peptides Proteins 0.000 description 2
150000003839 salts Chemical class 0.000 description 2
230000007480 spreading Effects 0.000 description 2
238000003892 spreading Methods 0.000 description 2
238000005303 weighing Methods 0.000 description 2
102000004127 Cytokines Human genes 0.000 description 1
108090000695 Cytokines Proteins 0.000 description 1
102000004190 Enzymes Human genes 0.000 description 1
108090000790 Enzymes Proteins 0.000 description 1
102000003886 Glycoproteins Human genes 0.000 description 1
108090000288 Glycoproteins Proteins 0.000 description 1
102000006771 Gonadotropins Human genes 0.000 description 1
108010086677 Gonadotropins Proteins 0.000 description 1
108010051696 Growth Hormone Proteins 0.000 description 1
102000018997 Growth Hormone Human genes 0.000 description 1
208000037357 HIV infectious disease Diseases 0.000 description 1
208000005176 Hepatitis C Diseases 0.000 description 1
102000008394 Immunoglobulin Fragments Human genes 0.000 description 1
108010021625 Immunoglobulin Fragments Proteins 0.000 description 1
102000004877 Insulin Human genes 0.000 description 1
108090001061 Insulin Proteins 0.000 description 1
102000004856 Lectins Human genes 0.000 description 1
108090001090 Lectins Proteins 0.000 description 1
201000005505 Measles Diseases 0.000 description 1
206010028980 Neoplasm Diseases 0.000 description 1
108091034117 Oligonucleotide Proteins 0.000 description 1
239000004698 Polyethylene Substances 0.000 description 1
239000004743 Polypropylene Substances 0.000 description 1
239000004793 Polystyrene Substances 0.000 description 1
102000003743 Relaxin Human genes 0.000 description 1
108090000103 Relaxin Proteins 0.000 description 1
102000011923 Thyrotropin Human genes 0.000 description 1
108010061174 Thyrotropin Proteins 0.000 description 1
241000700605 Viruses Species 0.000 description 1
JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
230000003213 activating effect Effects 0.000 description 1
230000004913 activation Effects 0.000 description 1
230000000890 antigenic effect Effects 0.000 description 1
230000001580 bacterial effect Effects 0.000 description 1
239000013060 biological fluid Substances 0.000 description 1
230000000903 blocking effect Effects 0.000 description 1
239000007853 buffer solution Substances 0.000 description 1
201000011510 cancer Diseases 0.000 description 1
230000008859 change Effects 0.000 description 1
238000010276 construction Methods 0.000 description 1
230000008878 coupling Effects 0.000 description 1
238000010168 coupling process Methods 0.000 description 1
238000005859 coupling reaction Methods 0.000 description 1
230000006378 damage Effects 0.000 description 1
230000007423 decrease Effects 0.000 description 1
239000003814 drug Substances 0.000 description 1
229940079593 drug Drugs 0.000 description 1
230000002550 fecal effect Effects 0.000 description 1
235000013305 food Nutrition 0.000 description 1
239000012520 frozen sample Substances 0.000 description 1
239000011521 glass Substances 0.000 description 1
150000004676 glycans Chemical class 0.000 description 1
239000010931 gold Substances 0.000 description 1
229910052737 gold Inorganic materials 0.000 description 1
239000002622 gonadotropin Substances 0.000 description 1
229940088597 hormone Drugs 0.000 description 1
239000005556 hormone Substances 0.000 description 1
208000033519 human immunodeficiency virus infectious disease Diseases 0.000 description 1
238000003384 imaging method Methods 0.000 description 1
229940127121 immunoconjugate Drugs 0.000 description 1
229940072221 immunoglobulins Drugs 0.000 description 1
208000015181 infectious disease Diseases 0.000 description 1
229940125396 insulin Drugs 0.000 description 1
239000002523 lectin Substances 0.000 description 1
229910052751 metal Inorganic materials 0.000 description 1
239000002184 metal Substances 0.000 description 1
150000002739 metals Chemical class 0.000 description 1
238000012986 modification Methods 0.000 description 1
230000004048 modification Effects 0.000 description 1
239000002808 molecular sieve Substances 0.000 description 1
230000003287 optical effect Effects 0.000 description 1
239000007793 ph indicator Substances 0.000 description 1
229920000573 polyethylene Polymers 0.000 description 1
229920001184 polypeptide Polymers 0.000 description 1
229920001155 polypropylene Polymers 0.000 description 1
229920001282 polysaccharide Polymers 0.000 description 1
239000005017 polysaccharide Substances 0.000 description 1
229920000136 polysorbate Polymers 0.000 description 1
229920002223 polystyrene Polymers 0.000 description 1
238000010791 quenching Methods 0.000 description 1
230000000171 quenching effect Effects 0.000 description 1
230000000717 retained effect Effects 0.000 description 1
238000005070 sampling Methods 0.000 description 1
238000000926 separation method Methods 0.000 description 1
150000003384 small molecules Chemical class 0.000 description 1
URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 1
238000005063 solubilization Methods 0.000 description 1
230000007928 solubilization Effects 0.000 description 1
239000002904 solvent Substances 0.000 description 1
241000894007 species Species 0.000 description 1
239000007921 spray Substances 0.000 description 1
238000010561 standard procedure Methods 0.000 description 1
150000008163 sugars Chemical class 0.000 description 1
229960000874 thyrotropin Drugs 0.000 description 1
230000001748 thyrotropin Effects 0.000 description 1
238000001291 vacuum drying Methods 0.000 description 1
230000003612 virological effect Effects 0.000 description 1
238000012800 visualization Methods 0.000 description 1

Classifications

- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54366—Apparatus specially adapted for solid-phase testing
- G01N33/54386—Analytical elements
- G01N33/54387—Immunochromatographic test strips
- G01N33/54388—Immunochromatographic test strips based on lateral flow
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/08—RNA viruses
- G01N2333/15—Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus, feline leukaemia virus, human T-cell leukaemia-lymphoma virus
- G01N2333/155—Lentiviridae, e.g. visna-maedi virus, equine infectious virus, FIV, SIV
- G01N2333/16—HIV-1, HIV-2
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/08—RNA viruses
- G01N2333/18—Togaviridae; Flaviviridae
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/575—Hormones
- G01N2333/59—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/805—Test papers
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/971—Capture of complex after antigen-antibody reaction
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/973—Simultaneous determination of more than one analyte
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/828—Protein A

Landscapes

Health & Medical Sciences (AREA)
Immunology (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Molecular Biology (AREA)
Biomedical Technology (AREA)
Chemical & Material Sciences (AREA)
Hematology (AREA)
Urology & Nephrology (AREA)
Biotechnology (AREA)
Microbiology (AREA)
Cell Biology (AREA)
Food Science & Technology (AREA)
Medicinal Chemistry (AREA)
Physics & Mathematics (AREA)
Analytical Chemistry (AREA)
Biochemistry (AREA)
General Health & Medical Sciences (AREA)
General Physics & Mathematics (AREA)
Pathology (AREA)
Investigating Or Analysing Biological Materials (AREA)
Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)

UAU200512159U 2003-06-06 2004-03-19 Diagnostic device for detecting analyte UA19871U (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US10/456,771 US7393697B2 (en)	2003-06-06	2003-06-06	Diagnostic test for analytes in a sample
PCT/US2004/008355 WO2005003732A2 (fr)	2003-06-06	2004-03-19	Essai diagnostique pour analytes dans un echantillon

Publications (1)

Publication Number	Publication Date
UA19871U true UA19871U (en)	2007-01-15

Family

ID=33490234

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
UAU200512159U UA19871U (en)	2003-06-06	2004-03-19	Diagnostic device for detecting analyte

Country Status (14)

Country	Link
US (1)	US7393697B2 (fr)
EP (1)	EP1658483B1 (fr)
JP (1)	JP4851321B2 (fr)
CN (1)	CN1902489B (fr)
AT (2)	AT9863U1 (fr)
AU (2)	AU2004254558A1 (fr)
BR (1)	BRPI0411059B8 (fr)
CA (1)	CA2528108C (fr)
CZ (1)	CZ16422U1 (fr)
DE (2)	DE602004030693D1 (fr)
DK (1)	DK200500290U4 (fr)
PT (1)	PT2005003732W (fr)
UA (1)	UA19871U (fr)
WO (1)	WO2005003732A2 (fr)

Families Citing this family (73)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2554904C (fr) *	2004-02-09	2013-01-22	Rapid Pathogen Screening Inc.	Procede de diagnostic rapide de cibles dans des liquides corporels humains
GB0412949D0 (en) *	2004-06-10	2004-07-14	Inverness Medical Switzerland	Improvements in or relating to lateral flow assay devices
US20060019406A1 (en) *	2004-07-23	2006-01-26	Ning Wei	Lateral flow device for the detection of large pathogens
US7387890B2 (en) *	2004-12-16	2008-06-17	Chembio Diagnostic Systems, Inc.	Immunoassay devices and use thereof
US8470608B2 (en) *	2008-05-20	2013-06-25	Rapid Pathogen Screening, Inc	Combined visual/fluorescence analyte detection test
US20090291508A1 (en) *	2008-05-20	2009-11-26	Rapid Pathogen Screening Inc.	Nanoparticles in diagnostic tests
US8614101B2 (en) *	2008-05-20	2013-12-24	Rapid Pathogen Screening, Inc.	In situ lysis of cells in lateral flow immunoassays
US8445293B2 (en)	2005-02-09	2013-05-21	Rapid Pathogen Screening, Inc.	Method to increase specificity and/or accuracy of lateral flow immunoassays
US8669052B2 (en)	2008-06-10	2014-03-11	Rapid Pathogen Screening, Inc.	Lateral flow nucleic acid detector
US7189522B2 (en)	2005-03-11	2007-03-13	Chembio Diagnostic Systems, Inc.	Dual path immunoassay device
WO2006098804A2 (fr)	2005-03-11	2006-09-21	Chembio Diagnostic Systems, Inc.	Dispositif de dosage immunologique a double trajet
US7939342B2 (en) *	2005-03-30	2011-05-10	Kimberly-Clark Worldwide, Inc.	Diagnostic test kits employing an internal calibration system
US20060292034A1 (en) *	2005-06-28	2006-12-28	American Bio Medica Corporation	Saliva sample testing device
WO2008014709A1 (fr) *	2006-07-26	2008-02-07	Abon Biopharm (Hangzhou) Co., Ltd.	Dispositif d'analyse d'un échantillon biologique
EP2152416A1 (fr) *	2007-04-20	2010-02-17	Quidel Corporation	Dispositifs d'analyse avec dessicatif intégré
CN101918837B (zh) *	2007-11-29	2014-01-29	美艾利尔瑞士公司	分析
JP4913025B2 (ja) *	2007-12-07	2012-04-11	富士フイルム株式会社	イムノクロマトグラフ方法
JP4428670B2 (ja) *	2008-03-06	2010-03-10	Ｔａｎａｋａホールディングス株式会社	免疫学的測定法、キット及び展開溶媒
US8609433B2 (en)	2009-12-04	2013-12-17	Rapid Pathogen Screening, Inc.	Multiplanar lateral flow assay with sample compressor
US9068981B2 (en)	2009-12-04	2015-06-30	Rapid Pathogen Screening, Inc.	Lateral flow assays with time delayed components
US20130196310A1 (en)	2008-05-20	2013-08-01	Rapid Pathogen Screening, Inc.	Method and Device for Combined Detection of Viral and Bacterial Infections
US9797898B2 (en)	2008-05-20	2017-10-24	Rapid Pathogen Screening, Inc.	Methods and devices for using mucolytic agents including N-acetyl cysteine (NAC)
US8962260B2 (en)	2008-05-20	2015-02-24	Rapid Pathogen Screening, Inc.	Method and device for combined detection of viral and bacterial infections
US8815609B2 (en)	2008-05-20	2014-08-26	Rapid Pathogen Screening, Inc.	Multiplanar lateral flow assay with diverting zone
CN101603967B (zh) *	2008-06-10	2015-02-18	英科新创(厦门)科技有限公司	快速检测人ABO/Rh/MN血型的方法及试剂盒
US20110086359A1 (en)	2008-06-10	2011-04-14	Rapid Pathogen Screening, Inc.	Lateral flow assays
US20100022916A1 (en)	2008-07-24	2010-01-28	Javanbakhsh Esfandiari	Method and Apparatus for Collecting and Preparing Biological Samples for Testing
EP2418488B1 (fr) *	2009-04-09	2015-08-12	ARKRAY, Inc.	Outil d'analyse d'echantillons, procede de fabrication d'outil d'analyse d'echantillons, et procede pour minimiser la baisse dans la permeabilite de solution d'organe de deploiement
CN101614739A (zh) *	2009-07-30	2009-12-30	杭州艾力康医药科技有限公司	丙型肝炎病毒抗体唾液快速检测试纸条
US8012770B2 (en)	2009-07-31	2011-09-06	Invisible Sentinel, Inc.	Device for detection of antigens and uses thereof
ES2461992T3 (es)	2009-10-09	2014-05-22	Invisible Sentinel, Inc.	Dispositivo para la detección de antígenos y usos de los mismos
JP4624477B1 (ja) *	2010-02-18	2011-02-02	田中貴金属工業株式会社	加工食品中の豚肉検出法およびその検出キット
JP4686639B1 (ja) *	2010-02-25	2011-05-25	田中貴金属工業株式会社	生豚肉検出法およびその検出キット
CN102236022B (zh) *	2010-04-26	2015-04-22	艾博生物医药(杭州)有限公司	一种检测装置
USD654185S1 (en)	2010-07-14	2012-02-14	Edward Lee	STD tester kit
CN102375054A (zh) *	2010-08-06	2012-03-14	艾博生物医药(杭州)有限公司	一种包括免疫试纸条的检测装置以及生产方法
AU2012211141B2 (en)	2011-01-27	2016-11-03	Invisible Sentinel, Inc.	Analyte detection devices, multiplex and tabletop devices for detection of analytes, and uses thereof
US8603835B2 (en)	2011-02-10	2013-12-10	Chembio Diagnostic Systems, Inc.	Reduced step dual path immunoassay device and method
CN103477226A (zh)	2011-03-31	2013-12-25	积水医疗株式会社	能将不含试样的样品确定为不当操作样品的免疫层析检测方法及其使用的测试条
EP2699699A4 (fr)	2011-04-18	2014-12-31	Garvan Inst Med Res	Procédé de diagnostic du cancer
WO2012151465A1 (fr)	2011-05-04	2012-11-08	Pop Test, Llc	Dispositif de diagnostic
KR101919330B1 (ko) *	2011-06-16	2018-11-19	후지필름 가부시키가이샤	고감도의 면역크로마토그래프 방법 및 면역크로마토그래프용 키트
CA2866379C (fr)	2012-03-09	2020-10-13	Invisible Sentinel, Inc.	Procedes et compositions pour detecter de multiples analytes avec un seul signal
GB201209664D0 (en) *	2012-05-30	2012-07-11	Spd Swiss Prec Diagnostics Gmbh	Assay device
CN104823051A (zh) *	2012-10-05	2015-08-05	韦拉克斯生物医学股份有限公司	多分析物试验
CN103558385A (zh) *	2013-11-18	2014-02-05	王勇	人类丙肝病毒(hcv)唾液/尿液抗体胶体金检测技术及其制备方法
GB201321430D0 (en) *	2013-12-04	2014-01-15	Spd Swiss Prec Diagnostics Gmbh	Assay device
GB201322011D0 (en) *	2013-12-12	2014-01-29	Ge Healthcare Ltd	Controlled transfer biological sample collection devices and methods of using such devices
US20170074849A1 (en) *	2014-03-06	2017-03-16	The Regents Of The University Of California	A test strip for melamine detection
SG11201608278WA (en)	2014-04-02	2016-10-28	Chembio Diagnostic Systems Inc	Immunoassay utilizing trapping conjugate
CN104316702B (zh) *	2014-05-30	2016-08-31	广州万孚生物技术股份有限公司	Pct与crp定量联检层析试纸条及其制备方法
AU2015318823A1 (en)	2014-09-15	2016-03-24	Garvan Institute Of Medical Research	Methods for diagnosis, prognosis and monitoring of breast cancer and reagents therefor
US20160116466A1 (en)	2014-10-27	2016-04-28	Chembio Diagnostic Systems, Inc.	Rapid Screening Assay for Qualitative Detection of Multiple Febrile Illnesses
CN104535768B (zh) *	2014-11-25	2016-06-22	东莞市莞信企业管理咨询有限公司	一种尿微量白蛋白检测装置
US10808287B2 (en)	2015-10-23	2020-10-20	Rapid Pathogen Screening, Inc.	Methods and devices for accurate diagnosis of infections
CN105486859B (zh) *	2015-11-20	2019-03-15	润和生物医药科技(汕头)有限公司	一种新型改进免疫层析试纸条及其制备和应用
CN105548495B (zh) *	2016-01-21	2018-04-10	浙江东方基因生物制品有限公司	一种准确高效的环保型检测装置
CN105548494B (zh) *	2016-01-21	2018-06-29	浙江东方基因生物制品有限公司	一种绿色环保型测试棒
US10983119B2 (en) *	2016-01-25	2021-04-20	General Electric Company	Device for rapid diagnostic tests to detect antigens with improved sensitivity
CA3010018A1 (fr) *	2016-01-27	2017-08-03	Undercover Colors, Inc.	Appareil pouvant etre porte pour detecter une substance cible dans un liquide
USD825075S1 (en)	2016-02-23	2018-08-07	Flora Bioscience, Inc.	Test strip holding device
CN105785050A (zh) *	2016-04-18	2016-07-20	石河子大学	一种利用胶体免疫金免疫渗滤法检测布鲁氏菌病的综合缓冲液
CN106290829A (zh) *	2016-07-19	2017-01-04	杭州博拓生物科技股份有限公司	一种四合一联合检测试纸盒及制备工艺
US20190120828A1 (en) *	2016-10-27	2019-04-25	Angela Renee Crumitie	Pregnancy test and keepsake device and method of use thereof
CN106970219A (zh) *	2017-04-28	2017-07-21	北京金豪制药股份有限公司	一种基于胶体金法检测尿液中hiv（1+2）抗体试剂
CN108226492A (zh) *	2018-01-05	2018-06-29	潍坊科瑞斯生物科技有限公司	A群猪轮状病毒快速elisa检测试剂盒
CN108761092A (zh) *	2018-07-18	2018-11-06	长春恒晓生物科技有限责任公司	建立时间分辨荧光免疫层析法检测和肽素试剂盒
WO2020086396A1 (fr) *	2018-10-23	2020-04-30	Boston Microfluidics, Inc.	Dispositif de collecte d'échantillon sanguin avec horodatage et échantillon environnemental simultané
CN110007076B (zh) *	2019-05-13	2024-02-27	无锡博慧斯生物医药科技有限公司	一种全血样本检测装置及其检测方法
KR20220161465A (ko) *	2020-03-31	2022-12-06	업카라 인코포레이티드	생물학적 시료에서 표적 분석물의 신속 검출을 위한 장치 및 방법
US11618032B2 (en)	2020-08-31	2023-04-04	International Business Machines Corporation	Multiplexed testing strip device
US12105099B2 (en) *	2021-04-28	2024-10-01	Diotex Diagnostics, Llc	Methods and devices for quantitatively estimating syndecan-1
CN115290892B (zh) *	2022-06-28	2023-04-21	北京美联泰科生物技术有限公司	一种缓冲液在脑特异性蛋白产物9.5检测试剂盒中的应用

Family Cites Families (46)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5622871A (en) *	1987-04-27	1997-04-22	Unilever Patent Holdings B.V.	Capillary immunoassay and device therefor comprising mobilizable particulate labelled reagents
SE388694B (sv) *	1975-01-27	1976-10-11	Kabi Ab	Sett att pavisa ett antigen exv i prov av kroppvetskor, med utnyttjande av till porost berarmaterial bundna eller adsorberande antikroppar
US4703017C1 (en) *	1984-02-14	2001-12-04	Becton Dickinson Co	Solid phase assay with visual readout
DE3445816C1 (de) *	1984-12-15	1986-06-12	Behringwerke Ag, 3550 Marburg	Flaechenfoermiges diagnostisches Mittel
US4960691A (en)	1986-09-29	1990-10-02	Abbott Laboratories	Chromatographic test strip for determining ligands or receptors
US4857453A (en) *	1987-04-07	1989-08-15	Syntex (U.S.A.) Inc.	Immunoassay device
DE3856542T2 (de) *	1987-04-27	2003-10-30	Inverness Medical Switzerland	Testgerät zur Durchführung von spezifischen Bindungsprüfungen
US4855240A (en)	1987-05-13	1989-08-08	Becton Dickinson And Company	Solid phase assay employing capillary flow
US4962023A (en)	1987-06-22	1990-10-09	Louisiana State University, Agricultural And Mechanical College	Single incubation immuno sorbent assay method using particle labels to detect test antigen specific antibodies in presence of other antibodies
EP0296298B1 (fr)	1987-06-24	1992-10-14	Howa Machinery Limited	Système de commande des mouvements de déplacement dans des machines du type à chariot
US4981786A (en)	1987-09-04	1991-01-01	Syntex (U.S.A.) Inc.	Multiple port assay device
AU2684488A (en) *	1988-06-27	1990-01-04	Carter-Wallace, Inc.	Test device and method for colored particle immunoassay
US5252496A (en) *	1989-12-18	1993-10-12	Princeton Biomeditech Corporation	Carbon black immunochemical label
WO1992012428A1 (fr) *	1991-01-11	1992-07-23	Quidel Corporation	Methode de dosage en une seule phase a flux lateral sur support non spongieux
JPH05126832A (ja) *	1991-10-31	1993-05-21	Fujirebio Inc	免疫分析装置及び免疫分析方法
TW213503B (fr)	1991-05-02	1993-09-21	Fujirebio Kk
US6168956B1 (en) *	1991-05-29	2001-01-02	Beckman Coulter, Inc.	Multiple component chromatographic assay device
JPH08262023A (ja) *	1991-12-30	1996-10-11	Fujirebio Inc	ストリップ分析装置
DE69405116T2 (de)	1993-11-12	1998-03-05	Unipath Ltd	Nachweis vorrichtung und herstellungsverfahren dafür
US5561045A (en) *	1994-01-04	1996-10-01	Intracel Corporation	Detection reagent, article, and immunoassay method
US5658801A (en) *	1994-05-03	1997-08-19	Spectral Diagnostics Inc.	Medical test kit
US6653066B1 (en) *	1994-06-17	2003-11-25	Trinity Biotech	Device and method for detecting polyvalent substances
JPH08136496A (ja) *	1994-11-02	1996-05-31	Taizo Uda	バイオセンサー
CA2167362A1 (fr) *	1995-02-10	1996-08-11	Alexei Dmitri Klimov	Appareil et methode pour la realisation d'un essai de liaisonnement entre deux materiaux absorbants
US5753517A (en) *	1996-03-29	1998-05-19	University Of British Columbia	Quantitative immunochromatographic assays
JP3859027B2 (ja) *	1996-12-18	2006-12-20	日本化薬株式会社	乳頭分泌液中の特定物質の測定方法
JP3640278B2 (ja) *	1996-12-20	2005-04-20	日本化薬株式会社	アッセイ装置およびそれを用いるアッセイ方法
JP3283435B2 (ja) *	1997-03-07	2002-05-20	松下電器産業株式会社	免疫クロマトグラフィー装置、およびその装置における試料液の保持方法
JP3786231B2 (ja) *	1997-07-31	2006-06-14	久光製薬株式会社	検査用デバイス
JP3773339B2 (ja) *	1997-11-07	2006-05-10	アボットジャパン株式会社	免疫分析用クロマトグラフィストリップ
EP0973034A1 (fr)	1998-07-16	2000-01-19	Microbe Scope AG	Immunoessais et dispositifs pour leur fonctionnement
EP1023600A4 (fr)	1998-07-29	2002-05-08	Syntron Biores Inc	Dispositif d'analyse immunologique
JP2000088851A (ja) *	1998-09-10	2000-03-31	Internatl Reagents Corp	生物学的特異反応測定法及び装置
GB9821526D0 (en)	1998-10-02	1998-11-25	Genosis Inc	Capture assay
JP4022005B2 (ja) *	1998-10-22	2007-12-12	わかもと製薬株式会社	簡易抗体検査方法及び検査用キット
AU2288200A (en)	1999-01-09	2000-08-01	Bernd Pevec	Method and device for determining an analyte
US6528323B1 (en) *	1999-06-14	2003-03-04	Praxsys Biosystems, Inc.	Bidirectional lateral flow test strip and method
SE9904175D0 (sv)	1999-11-18	1999-11-18	Pharmacia & Upjohn Diag Ab	Assay device and use thereof
US6316205B1 (en) *	2000-01-28	2001-11-13	Genelabs Diagnostics Pte Ltd.	Assay devices and methods of analyte detection
JP3680090B2 (ja) *	2000-05-25	2005-08-10	株式会社ニチレイ	分析装置
US6372516B1 (en) *	2000-09-07	2002-04-16	Sun Biomedical Laboratories, Inc.	Lateral flow test device
US6528325B1 (en) *	2000-10-13	2003-03-04	Dexall Biomedical Labs, Inc.	Method for the visual detection of specific antibodies in human serum by the use of lateral flow assays
CA2429372A1 (fr)	2001-01-03	2002-08-29	Heska Corporation	Detection d'ige specifique d'allergenes
US6492127B2 (en) *	2001-01-23	2002-12-10	Varian, Inc.	Lateral flow testing device with on-board chemical reactant
WO2003016902A1 (fr) *	2001-08-20	2003-02-27	Proteome Systems Intellectual Property Pty Ltd	Procede et appareil d'epreuve diagnostique
JP2003107090A (ja) *	2001-09-28	2003-04-09	Nitto Denko Corp	免疫クロマトグラフ用標識複合体組成物

2003
- 2003-06-06 US US10/456,771 patent/US7393697B2/en not_active Expired - Lifetime
2004
- 2004-03-19 WO PCT/US2004/008355 patent/WO2005003732A2/fr not_active Ceased
- 2004-03-19 DE DE602004030693T patent/DE602004030693D1/de not_active Expired - Lifetime
- 2004-03-19 CA CA2528108A patent/CA2528108C/fr not_active Expired - Lifetime
- 2004-03-19 DE DE212004000032U patent/DE212004000032U1/de not_active Expired - Lifetime
- 2004-03-19 CZ CZ200517219U patent/CZ16422U1/cs not_active IP Right Cessation
- 2004-03-19 UA UAU200512159U patent/UA19871U/uk unknown
- 2004-03-19 AT AT0900504U patent/AT9863U1/de not_active IP Right Cessation
- 2004-03-19 EP EP04785762A patent/EP1658483B1/fr not_active Expired - Lifetime
- 2004-03-19 BR BRPI0411059A patent/BRPI0411059B8/pt not_active IP Right Cessation
- 2004-03-19 JP JP2006509248A patent/JP4851321B2/ja not_active Expired - Lifetime
- 2004-03-19 AT AT04785762T patent/ATE492814T1/de not_active IP Right Cessation
- 2004-03-19 CN CN2004800157727A patent/CN1902489B/zh not_active Expired - Lifetime
- 2004-03-19 PT PT2004008355A patent/PT2005003732W/pt unknown
- 2004-03-19 AU AU2004254558A patent/AU2004254558A1/en not_active Abandoned
2005
- 2005-12-19 DK DK200500290U patent/DK200500290U4/da not_active IP Right Cessation
2010
- 2010-04-22 AU AU2010201632A patent/AU2010201632A1/en not_active Abandoned

Also Published As

Publication number	Publication date
JP4851321B2 (ja)	2012-01-11
CN1902489B (zh)	2012-07-04
US7393697B2 (en)	2008-07-01
WO2005003732A3 (fr)	2006-07-27
DE602004030693D1 (de)	2011-02-03
CA2528108C (fr)	2013-06-11
WO2005003732A2 (fr)	2005-01-13
CN1902489A (zh)	2007-01-24
HK1084183A1 (en)	2006-07-21
BRPI0411059B1 (pt)	2016-08-23
DE212004000032U1 (de)	2006-04-06
CZ16422U1 (cs)	2006-04-10
JP2007524813A (ja)	2007-08-30
EP1658483A4 (fr)	2007-04-04
CA2528108A1 (fr)	2005-01-13
BRPI0411059B8 (pt)	2021-07-27
PT2005003732W (pt)	2007-12-13
AU2010201632A1 (en)	2010-05-20
DK200500290U4 (da)	2007-04-13
EP1658483A2 (fr)	2006-05-24
AU2004254558A1 (en)	2005-01-13
AT9863U1 (de)	2008-04-15
EP1658483B1 (fr)	2010-12-22
BRPI0411059A (pt)	2006-08-01
ATE492814T1 (de)	2011-01-15
US20040248322A1 (en)	2004-12-09
DK200500290U1 (da)	2006-04-28

Publication	Publication Date	Title
UA19871U (en)	2007-01-15	Diagnostic device for detecting analyte
JP2948318B2 (ja)	1999-09-13	特異的結合アッセイ用の赤血球の分離方法
KR102209489B1 (ko)	2021-02-02	바이러스 및 박테리아 감염의 복합 검출을 위한 방법 및 장치
JP4846573B2 (ja)	2011-12-28	基準としての天然分析物を有するラテラルフローアッセイ装置および方法
US10379121B2 (en)	2019-08-13	Method and device for combined detection of viral and bacterial infections
KR101337020B1 (ko)	2013-12-05	신속 진단용 검사 장치
US8962260B2 (en)	2015-02-24	Method and device for combined detection of viral and bacterial infections
JP5276568B2 (ja)	2013-08-28	アッセイ用デバイス
JP5430995B2 (ja)	2014-03-05	アッセイ方法およびアッセイ用デバイス
JP7130045B2 (ja)	2022-09-02	イムノクロマトグラフキットおよび結核菌の検出方法
JP7425883B2 (ja)	2024-01-31	濃縮デバイス、検体液の濃縮方法、検体液の検査方法、及び、検査キット
EP3872491B1 (fr)	2023-06-07	Échantillon de test pour une immunochromatographie
JP2010032396A (ja)	2010-02-12	バイオセンサ
RU58717U1 (ru)	2006-11-27	Диагностическая испытательная полоска
KR200417666Y1 (ko)	2006-06-02	시료 내의 분석 대상 물질을 검출하기 위한 진단 테스트스트립
US20240077478A1 (en)	2024-03-07	System for rapid analysis of a capillary blood sample from a subject, intended for detecting the presence of at least one analyte in said capillary blood sample
HK1084183B (en)	2011-09-02	Diagnostic test for analytes in a sample